VIDEO & ARTICLE See how doctors implant a deep-brain-stimulation device in “The Advance Study”. Learn how its electrodes stimulate a part of the brain called
From Alzheimer’s & Parkinson’s to multiple sclerosis & amyotrophic lateral sclerosis (Lou Gehrig’s disease), existing therapies focus on simply trying to preserve neurons or slow
VIDEO & ARTICLE A new online report from the National Institutes of Health (NIH) highlights recent progress in NIH-supported Alzheimer’s disease research. Watch Director Dr.
Agitation can be a disruptive, chronic problem in Alzheimer’s. It increases caregiver burden as well as patient distress and is often the trigger to long-term
Can new MRI technology effectively & non-invasively diagnose the type of dementia that is afflicting a person?
In 2012, Envivo’s experimental Alzheimer’s drugs improved cognitive function as the company won a Fierce BioTech Award. Learn about and participate in their newest Phase-2
BioWorld’s top 10 stories for 2012 included the puzzling outcome of some massive Alzheimer’s trials. Find out how we are more-sure-than-ever of what ought to
Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer’s disease. Find out
See a robot with a biological brain made of cultured neurons. Find out why this may hold a key to treating dementia, stroke & brain injury.
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
Even in later life, quitting smoking significantly reduces dementia risk.
New research published in The Lancet offers renewed hope — it’s never too late to protect your brain.
Some everyday medicines may nudge dementia risk higher — but safer, equally effective alternatives often exist. Here’s how to replace high-risk drugs with brain-friendlier options
A simple blood test was newly approved, replacing spinal taps and brain scans for ruling out Alzheimer’s. The FDA has just cleared Roche’s Elecsys® pTau181 — the first test shown to rule out Alzheimer’s with 98% accuracy, offering peace of mind and earlier answers for millions.
Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.
Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.
Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.
A deep promise to be there for an Alzheimer’s parent, this heartwarming song was written as a tribute to families facing dementia.
No spam, only news and updates.
